GlassScriptPhysician profile
George M Thurber
NPI 1194839779
$7,506.59
in general payments reported to CMS, 2019-2025
18 companies · $404 in 2025
The $404 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,868 · 2020: $446 · 2021: $905 · 2022: $1,123 · 2023: $1,146 · 2024: $616 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,165.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $3,923.81 | 2019-2025 | Catalys System, Tecnis Iol, Tecnis Iol |
| Glaukos Corporation | $1,008.41 | 2020-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idosetr |
| Abbvie INC. | $773.87 | 2022-2025 | Durysta |
| Allergan, INC. | $566.89 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $327.81 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $265.02 | 2022-2025 | Miebo, Vyzulta, Lotemax Sm |
| Mallinckrodt Hospital Products INC. | $133.10 | 2022-2023 | Acthar |
| Alcon Vision LLC | $113.60 | 2022-2024 | Rocklatan |
| Aerie Pharmaceuticals, INC. | $83.64 | 2020-2021 | |
| Ocular Therapeutix, INC. | $54.59 | 2023-2024 | Dextenza |
| Kala Pharmaceuticals, INC. | $46.80 | 2019-2021 | |
| Oyster Point Pharma, INC. | $46.64 | 2022 | |
| Sight Sciences, INC. | $42.61 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Rayner Intraocular Lenses Limited | $37.53 | 2024 | Omidria |
| Harrow Eye, LLC | $36.63 | 2024 | Vevye |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $22.86 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.76 | 2019 | |
| New World Medical,INC. | $9.02 | 2024 | Ahmed Glaucoma Valve, Clearpath, Streamline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Thurber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.